Literature DB >> 24748032

An alkali-burn injury model of corneal neovascularization in the mouse.

Chastain Anderson, Qinbo Zhou, Shusheng Wang1.   

Abstract

Under normal conditions, the cornea is avascular, and this transparency is essential for maintaining good visual acuity. Neovascularization (NV) of the cornea, which can be caused by trauma, keratoplasty or infectious disease, breaks down the so called 'angiogenic privilege' of the cornea and forms the basis of multiple visual pathologies that may even lead to blindness. Although there are several treatment options available, the fundamental medical need presented by corneal neovascular pathologies remains unmet. In order to develop safe, effective, and targeted therapies, a reliable model of corneal NV and pharmacological intervention is required. Here, we describe an alkali-burn injury corneal neovascularization model in the mouse. This protocol provides a method for the application of a controlled alkali-burn injury to the cornea, administration of a pharmacological compound of interest, and visualization of the result. This method could prove instrumental for studying the mechanisms and opportunities for intervention in corneal NV and other neovascular disorders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24748032      PMCID: PMC4164081          DOI: 10.3791/51159

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  19 in total

1.  [Angiogenesis and lymphangiogenesis in the cornea. Pathogenesis, clinical implications and treatment options].

Authors:  C Cursiefen; B Seitz; M R Dana; J W Streilein
Journal:  Ophthalmologe       Date:  2003-04       Impact factor: 1.059

2.  Standard models of corneal injury using alkali-immersed filter discs.

Authors:  L D Ormerod; M B Abelson; K R Kenyon
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-10       Impact factor: 4.799

3.  Corneal avascularity is due to soluble VEGF receptor-1.

Authors:  Balamurali K Ambati; Miho Nozaki; Nirbhai Singh; Atsunobu Takeda; Pooja D Jani; Tushar Suthar; Romulo J C Albuquerque; Elizabeth Richter; Eiji Sakurai; Michael T Newcomb; Mark E Kleinman; Ruth B Caldwell; Qing Lin; Yuichiro Ogura; Angela Orecchia; Don A Samuelson; Dalen W Agnew; Judy St Leger; W Richard Green; Parameshwar J Mahasreshti; David T Curiel; Donna Kwan; Helene Marsh; Sakae Ikeda; Lucy J Leiper; J Martin Collinson; Sasha Bogdanovich; Tejvir S Khurana; Masabumi Shibuya; Megan E Baldwin; Napoleone Ferrara; Hans-Peter Gerber; Sandro De Falco; Jassir Witta; Judit Z Baffi; Brian J Raisler; Jayakrishna Ambati
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

4.  Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis.

Authors:  Franziska Bucher; Anand Parthasarathy; Antonio Bergua; Jasmine Onderka; Birgit Regenfuss; Claus Cursiefen; Felix Bock
Journal:  Acta Ophthalmol       Date:  2012-09-20       Impact factor: 3.761

5.  Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury.

Authors:  Gabriel Sosne; Patricia L Christopherson; Ronald P Barrett; Rafael Fridman
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-07       Impact factor: 4.799

Review 6.  Corneal blindness: a global perspective.

Authors:  J P Whitcher; M Srinivasan; M P Upadhyay
Journal:  Bull World Health Organ       Date:  2003-07-07       Impact factor: 9.408

7.  Therapeutic effects of adenoviral gene transfer of bone morphogenic protein-7 on a corneal alkali injury model in mice.

Authors:  Shizuya Saika; Kazuo Ikeda; Osamu Yamanaka; Kathleen C Flanders; Yuji Nakajima; Takeshi Miyamoto; Yoshitaka Ohnishi; Winston W-Y Kao; Yasuteru Muragaki; Akira Ooshima
Journal:  Lab Invest       Date:  2005-04       Impact factor: 5.662

8.  Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.

Authors:  Efdal Yoeruek; Focke Ziemssen; Sigrid Henke-Fahle; Olcay Tatar; Aysegül Tura; Salvatore Grisanti; Karl U Bartz-Schmidt; Peter Szurman
Journal:  Acta Ophthalmol       Date:  2007-11-08       Impact factor: 3.761

9.  VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment.

Authors:  Claus Cursiefen; Lu Chen; Leonardo P Borges; David Jackson; Jingtai Cao; Czeslaw Radziejewski; Patricia A D'Amore; M Reza Dana; Stanley J Wiegand; J Wayne Streilein
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

10.  Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis.

Authors:  Kip M Connor; Nathan M Krah; Roberta J Dennison; Christopher M Aderman; Jing Chen; Karen I Guerin; Przemyslaw Sapieha; Andreas Stahl; Keirnan L Willett; Lois E H Smith
Journal:  Nat Protoc       Date:  2009-10-08       Impact factor: 13.491

View more
  26 in total

1.  Deterioration of wound healing and intense suppression of MMP-9 mRNA expression after short-term administration of different topical glucocorticoids or NSAIDs in an avian model of corneal lesions.

Authors:  H Mirarab Razi; N Mosleh; T Shomali; N Tavangar; F Namazi
Journal:  Iran J Vet Res       Date:  2021       Impact factor: 1.376

2.  Safety, efficacy and delivery of multiple nucleoside analogs via drug encapsulated carbon (DECON) based sustained drug release platform.

Authors:  Tejabhiram Yadavalli; Joshua Ames; David Wu; Benjamin Ramirez; Navya Bellamkonda; Deepak Shukla
Journal:  Eur J Pharm Biopharm       Date:  2022-03-21       Impact factor: 5.589

3.  Ocular surgical models for immune and angiogenic responses.

Authors:  Takenori Inomata; Alireza Mashaghi; Antonio Di Zazzo; Reza Dana
Journal:  J Biol Methods       Date:  2015-09-21

Review 4.  Angiogenesis and lymphangiogenesis in corneal transplantation-A review.

Authors:  Wei Zhong; Mario Montana; Samuel M Santosa; Irene D Isjwara; Yu-Hui Huang; Kyu-Yeon Han; Christopher O'Neil; Ashley Wang; Maria Soledad Cortina; Jose de la Cruz; Qiang Zhou; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar
Journal:  Surv Ophthalmol       Date:  2017-12-27       Impact factor: 6.048

5.  Recombinant Human MG53 Protein Protects Against Alkaline-Induced Corneal Injuries in Mice.

Authors:  Owen Guo; Brent Ju; McKinley H Shawver; Bingchuan Geng; Siqi Wei; Terriah Early; Frank Yi; Tao Tan; Heather L Chandler; Jianjie Ma; Hua Zhu
Journal:  Mil Med       Date:  2021-01-25       Impact factor: 1.437

6.  Biomaterials-enabled cornea regeneration in patients at high risk for rejection of donor tissue transplantation.

Authors:  M Mirazul Islam; Oleksiy Buznyk; Jagadesh C Reddy; Nataliya Pasyechnikova; Keith M Meek; Virender S Sangwan; May Griffith; Emilio I Alarcon; Sally Hayes; Philip Lewis; Per Fagerholm; Chaoliang He; Stanislav Iakymenko; Wenguang Liu
Journal:  NPJ Regen Med       Date:  2018-01-31

7.  Role of microRNA 146a on the healing of cornea alkali burn treated with mesenchymal stem cells.

Authors:  Xu Luo; Jianmin Li; Lihui Yin; Jian Pan; Yang Zhang; Zipei Jiang
Journal:  Mol Med Rep       Date:  2018-07-27       Impact factor: 2.952

8.  Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn.

Authors:  Kislay Roy; Bhasker Sriramoju; Rupinder K Kanwar; Jagat R Kanwar
Journal:  Front Pharmacol       Date:  2016-07-28       Impact factor: 5.810

9.  Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib.

Authors:  Tong Lin; Lan Gong
Journal:  Drug Des Devel Ther       Date:  2017-04-05       Impact factor: 4.162

10.  Topical Use of Angiopoietin-like Protein 2 RNAi-loaded Lipid Nanoparticles Suppresses Corneal Neovascularization.

Authors:  Yukako Taketani; Tomohiko Usui; Tetsuya Toyono; Nobuyuki Shima; Seiichi Yokoo; Mikiko Kimakura; Satoru Yamagami; Shinichiro Ohno; Risako Onodera; Kohei Tahara; Hirofumi Takeuchi; Masahiko Kuroda
Journal:  Mol Ther Nucleic Acids       Date:  2016-03-08       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.